JP2023527834A5 - - Google Patents
Info
- Publication number
- JP2023527834A5 JP2023527834A5 JP2022572759A JP2022572759A JP2023527834A5 JP 2023527834 A5 JP2023527834 A5 JP 2023527834A5 JP 2022572759 A JP2022572759 A JP 2022572759A JP 2022572759 A JP2022572759 A JP 2022572759A JP 2023527834 A5 JP2023527834 A5 JP 2023527834A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- risk
- coronavirus infection
- subject
- developing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020901739 | 2020-05-27 | ||
| AU2020901739A AU2020901739A0 (en) | 2020-05-27 | Methods of assessing risk of developing a severe response to Coronavirus infection | |
| AU2020902052 | 2020-06-19 | ||
| AU2020902052A AU2020902052A0 (en) | 2020-06-19 | Methods of assessing risk of developing a severe response to Coronavirus infection | |
| AU2020903536 | 2020-09-30 | ||
| AU2020903536A AU2020903536A0 (en) | 2020-09-30 | Methods of assessing risk of developing a severe response to coronavirus infection | |
| AU2021900392A AU2021900392A0 (en) | 2021-02-17 | Methods of assessing risk of developing a severe response to Coronavirus infection | |
| AU2021900392 | 2021-02-17 | ||
| PCT/AU2021/050507 WO2021237292A1 (en) | 2020-05-27 | 2021-05-26 | Methods of assessing risk of developing a severe response to coronavirus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527834A JP2023527834A (ja) | 2023-06-30 |
| JP2023527834A5 true JP2023527834A5 (enExample) | 2024-06-05 |
Family
ID=78745661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572759A Pending JP2023527834A (ja) | 2020-05-27 | 2021-05-26 | コロナウイルス感染に重度の応答を発症するリスクを評価する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11257569B1 (enExample) |
| EP (1) | EP4158067A4 (enExample) |
| JP (1) | JP2023527834A (enExample) |
| KR (1) | KR20230019872A (enExample) |
| CN (1) | CN116134152A (enExample) |
| AU (1) | AU2021281702A1 (enExample) |
| CA (1) | CA3179313A1 (enExample) |
| IL (1) | IL298097A (enExample) |
| MX (1) | MX2022014931A (enExample) |
| WO (1) | WO2021237292A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023006518A (es) * | 2020-12-03 | 2023-06-23 | Regeneron Pharma | Metodos de identificacion de sujetos que tienen un mayor riesgo de desarrollar una infeccion por coronavirus y su tratamiento. |
| US20230278029A1 (en) * | 2022-03-01 | 2023-09-07 | Dnanudge Limited | Multiplex cartridge for detection of viral nucleic acids and human or animal snps |
| WO2023194369A1 (en) * | 2022-04-08 | 2023-10-12 | Fundació Institut Mar D'investigacions Mèdiques (Imim) | Genetic markers for severe covid-19 |
| CN117198517B (zh) * | 2023-06-27 | 2024-04-30 | 安徽省立医院(中国科学技术大学附属第一医院) | 基于机器学习的运动反应性评估和预测模型的建模方法 |
| PL248077B1 (pl) * | 2023-10-10 | 2025-10-13 | Biolab Genetic Spolka Z Ograniczona Odpowiedzialnoscia | Sposób określania poziomu ryzyka ciężkiego przebiegu choroby COVID-19 u pacjenta |
| PL249351B1 (pl) * | 2023-10-10 | 2026-03-30 | Biolab Genetic Spółka Z Ograniczoną Odpowiedzialnością | Zestaw i sposób do określania metodą łańcuchowej reakcji polimerazy układu alleli w locus rs143334143 oraz rs74956615 |
| CN121458076B (zh) * | 2026-01-08 | 2026-04-03 | 山西唐讯科技有限公司 | 输电线可视化监测数据智能分析和预警方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5714330A (en) | 1994-04-04 | 1998-02-03 | Lynx Therapeutics, Inc. | DNA sequencing by stepwise ligation and cleavage |
| US5695934A (en) | 1994-10-13 | 1997-12-09 | Lynx Therapeutics, Inc. | Massively parallel sequencing of sorted polynucleotides |
| US5750341A (en) | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
| JP4540754B2 (ja) | 1996-06-04 | 2010-09-08 | ユニバーシティ オブ ユタ リサーチ ファウンデーション | Ｐｃｒ中のハイブリダイゼーションのモニタリング |
| US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
| US6511803B1 (en) | 1997-10-10 | 2003-01-28 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
| US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
| AU7537200A (en) | 1999-09-29 | 2001-04-30 | Solexa Ltd. | Polynucleotide sequencing |
| US6898531B2 (en) | 2001-09-05 | 2005-05-24 | Perlegen Sciences, Inc. | Algorithms for selection of primer pairs |
| US20030108919A1 (en) | 2001-09-05 | 2003-06-12 | Perlegen Sciences, Inc. | Methods for amplification of nucleic acids |
| CA2513899C (en) | 2003-01-29 | 2013-03-26 | 454 Corporation | Methods of amplifying and sequencing nucleic acids |
| CN1768140B (zh) * | 2003-03-24 | 2010-06-16 | 港大科桥有限公司 | 对引起严重急性呼吸道综合症(sars)的人病毒的高通量诊断性试验 |
| US7127355B2 (en) | 2004-03-05 | 2006-10-24 | Perlegen Sciences, Inc. | Methods for genetic analysis |
| EP2044221B1 (en) * | 2006-07-21 | 2015-07-22 | Epigenomics AG | Methods and kit for analyses of methylation in colorectal cellular proliferative disorders |
| DK2438193T3 (en) * | 2009-06-01 | 2015-10-19 | Genetic Technologies Ltd | Methods for assessing the risk of breast cancer |
| CA2962691C (en) * | 2014-09-30 | 2023-05-23 | Genetic Technologies Limited | Methods for assessing risk of developing breast cancer |
| US20200102617A1 (en) * | 2017-01-24 | 2020-04-02 | Genetic Technologies Limited | Improved Methods For Assessing Risk of Developing Breast Cancer |
| US10643951B2 (en) * | 2017-07-14 | 2020-05-05 | Taiwan Semiconductor Manufacturing Co., Ltd. | Mini identification mark in die-less region of semiconductor wafer |
| WO2021016391A1 (en) * | 2019-07-23 | 2021-01-28 | The Broad Institute, Inc. | Health data aggregation and outbreak modeling |
| US20210340636A1 (en) * | 2020-03-31 | 2021-11-04 | Diasorin S.P.A. | Assays for the Detection of SARS-CoV-2 |
-
2021
- 2021-05-26 KR KR1020227045938A patent/KR20230019872A/ko not_active Withdrawn
- 2021-05-26 CA CA3179313A patent/CA3179313A1/en active Pending
- 2021-05-26 JP JP2022572759A patent/JP2023527834A/ja active Pending
- 2021-05-26 CN CN202180048201.7A patent/CN116134152A/zh active Pending
- 2021-05-26 MX MX2022014931A patent/MX2022014931A/es unknown
- 2021-05-26 WO PCT/AU2021/050507 patent/WO2021237292A1/en not_active Ceased
- 2021-05-26 IL IL298097A patent/IL298097A/en unknown
- 2021-05-26 EP EP21813074.8A patent/EP4158067A4/en not_active Withdrawn
- 2021-05-26 AU AU2021281702A patent/AU2021281702A1/en not_active Abandoned
- 2021-07-06 US US17/368,471 patent/US11257569B1/en not_active Expired - Fee Related
-
2022
- 2022-02-08 US US17/667,282 patent/US20220246242A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023527834A5 (enExample) | ||
| Dubois et al. | Multiple common variants for celiac disease influencing immune gene expression | |
| Booij et al. | A gene expression pattern in blood for the early detection of Alzheimer's disease | |
| Khush | Clinical utility of donor-derived cell-free DNA testing in cardiac transplantation | |
| JP2019510473A5 (enExample) | ||
| JP2016082984A (ja) | 遺伝子分析のための方法 | |
| JP2014528576A5 (enExample) | ||
| JP7748472B2 (ja) | 脳卒中の多遺伝子性遺伝的リスクスコア及び発症リスク評価装置並びにその使用 | |
| JP2017529859A5 (enExample) | ||
| WO2022247903A1 (zh) | 冠心病多基因遗传风险评分及其构建方法与联合临床风险评估应用 | |
| Hu et al. | Dectin-2 polymorphism associated with pulmonary cryptococcosis in HIV-uninfected Chinese patients | |
| Haks et al. | Focused human gene expression profiling using dual-color reverse transcriptase multiplex ligation-dependent probe amplification | |
| CN107760779A (zh) | 肺动脉高压相关的突变型bmp9基因及其应用 | |
| Wang et al. | Genomic bacterial load associated with bacterial genotypes and clinical characteristics in patients with scrub typhus in Hainan Island, Southern China | |
| US20170101678A1 (en) | Method for screening risk of drug-induced toxicity | |
| Suzuki et al. | A double heterozygous variant in MYH6 and MYH7 associated with hypertrophic cardiomyopathy in a Japanese Family | |
| CN110106251A (zh) | 用于冠心病发病风险预测的单核苷酸多态性位点的组合、试剂盒及芯片 | |
| ES2340459B1 (es) | Metodo para diagnosticar o determinar la predisposicion genetica a desarrollar miocardiopatia hipertrofica. | |
| Agung Prasetyo et al. | The-1082 A allele of the interleukin-10 single nucleotide polymorphism-1082 G/A is associated with hepatitis virus co-infection in Indonesian Javanese HIV patients | |
| KR102724742B1 (ko) | 선천적 대사질환 위험도 점수를 이용한 심뇌혈관질환의 위험도 측정 방법 | |
| CN110914453A (zh) | 动脉粥样硬化性心血管疾病的生物标志物 | |
| CN113667665A (zh) | 家族性高胆固醇血症相关基因及其检测试剂盒与应用 | |
| US8445208B2 (en) | Multivariate analysis involving genetic polymorphisms related to mediators of inflammatory response for prediction of outcome of critcally ill patients | |
| Xu et al. | C‐Reactive Protein+ 1444C/T Polymorphism Is Associated with the Susceptibility to Pulmonary Tuberculosis | |
| Mariana Barros Melo da Silveira et al. | The role of galectin-3 in patients with permanent and paroxysmal Atrial Fibrillation and echocardiographic parameters of left atrial fibrosis |